Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. I. Taxonomy, fermentation, isolation, and physico-chemical properties and biological activities

Journal of Antibiotics

Volumn 50, Issue 1, 1997, Pages 58-65

  Tanaka, Haruo ^a   Matsuzaki, Keiichi ^a   Nakashima, Hideki ^c   Ogino, Tomoaki ^a   Matsumoto, Atsuko ^b   Ikeda, Hodaka ^a   Woodruff, H Boyd ^b   Omura, Satoshi ^b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CHLOROPEPTIN 1; CHLOROPEPTIN 2; COMPLESTATIN; DIDANOSINE; GLYCOPROTEIN GP 120; NEVIRAPINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; FERMENTATION; HELA CELL; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STREPTOMYCES; SYNCYTIUM; TAXONOMY;

EID: 0031058263     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.58     Document Type: Article

References (21)

1. + T cells by a complex of the 110 K viral protein and the T4 molecule. Science 231: 382-385, 1986
2. SADROSKI, J.; W. C. GOH, C. ROSEN, K. CAMPBELL & W. A. HASELTIME: Role of HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322: 470-474, 1986
3. LIFSON, J. D.; M. B. FEINBERG, G. R. REYES, L. RABIN, B. BANAPOUR, S. CHAKRABARTI, B. MOSS, F. WONG-STAAL, K. S. STEIMER & E. G. ENGLEMAN: Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 323: 725-728, 1986
4. JOHNSTON, M. I. & D. F. HOTH: Present status and future prospects for HIV therapies. Science 260: 1286-1293, 1993
5. ŌMURA, S.; H. TANAKA, K. MATSUZAKI, H. IKEDA & R. MASUMA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp. J. Antibiotics 46: 1908-1911, 1993
6. MATSUZAKI, K.; H. IKEDA, R. MASUMA, H. TANAKA & S. ŌMURA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338. I. Screening, taxonomy, fermentation, isolation and biological activity J. Antibiotics 48: 703-707, 1995
7. MATSUZAKI, K.; H. TANAKA & S. ŌMURA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338. II. Stricture elucidation. J. Antibiotics 48: 708-713, 1995
8. MATSUZAKI, K.; H. IKEDA, T. OGINO, A. MATSUMOTO, H. B. WOODRUFF, H. TANAKA & S. ŌMURA: Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces. sp. J. Antibiotics 47: 1173-1174, 1994
9. MATSUZAKI, K.; T. OGINO, T. SUNAZUKA, H. TANAKA & S. ŌMURA: Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. II. Structure elucidation of chloropeptin I. J. Antibiotics 50: 66-69, 1997
10. SHIRLING, E. B. & D. GOTTLIEB: Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313-340, 1966
11. WAKSMAN, S. A. (Ed.): Classification, identification and description of genera and species. In The Actinomycetes. Vol. 2. Williams and Wilkins Co., Baltimore, 1961
12. Container Corporation of America: Color Harmony Manual 4th. Ed. Chicago, 1958
13. PRIDHAM, T.; G. & D. GOTTLIEB: The utilization of carbon compounds by some Actinomycetales as an aid for species determination. J. Bacteriol. 56: 107-114, 1948
14. BECKER, B.; M. P. LECHEVALIER & H. A. LECHEVALIER: Chemical composition of cell-wall preparation from strains of various form-genera of aerobic actinomycetes. Appl. Microbiol. 13: 236-243, 1965
15. GILBERT, M.; J. KIRIHARA & J. MILLS: Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J. Clin. Microbiol. 29: 142-147, 1991
16. NAKASHIMA, H.; K. ICHIYAMA, K. INAZAWA, M. ITO, H. HAYASHI, Y. NISHIHARA, E. TSUJII & T. KINO: FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2′,3′-dideoxynucleosides. Biol. Pharm. Bull. 19: 405-412, 1996
17. PRICHARD, M. N. & C. SHIPMAN, Jr.: A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 14: 181-205, 1990
18. WILLIAMS, S. T.; M. GOODFELLOW & G. ALDERSON: Genus Streptomyces Waksman and Henrici 1943. In BERGEY'S Manual of Systematic Bacteriology. Volume 4. Ed., S. T. WILIAMS et al., pp. 2452-2492, Williams & Wilkins Co., 1989
19. KANEKO, I.; K. KAMOSHIDA & S. TAKAHASHI: Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization. J. Antibiotics 42: 236-241, 1989
20. SETO, H.; T. FUJIOKA, K. FURIHATA, I. KANEKO & S. TAKAHASHI: Structure of complestatin, a very strong inhibitor of protease activity of complement in the human complement system. Tetrahedron Lett. 30: 4987-4990, 1989
21. MOMOTA, K.; I. KANEKO, S. KIMURA, K. MITAMURA & K. SHIMADA: Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin. Biochem. Biophys. Res. Comm. 179: 243-250, 1991